Skip to main content
KOBAYASHI PHARMACEUTICAL CO.,LTD. logo

KOBAYASHI PHARMACEUTICAL CO.,LTD. — Investor Relations & Filings

Ticker · 4967 ISIN · JP3301100008 LEI · 529900WBSL04KD6TKP95 T Manufacturing
Open in API
Filings indexed 74 across all filing types
Latest filing 2023-08-10 Regulatory Filings
Country JP Japan
Listing T 4967

About KOBAYASHI PHARMACEUTICAL CO.,LTD.

https://www.kobayashi.co.jp/english/

Kobayashi Pharmaceutical Co., Ltd. is a company engaged in the development, manufacturing, and marketing of a wide range of consumer products. Its core business segments include over-the-counter (OTC) pharmaceuticals, health and personal care items, and household goods. The company's diverse product portfolio features items such as nutritional supplements, deodorizing air fresheners, and disposable body warmers. Kobayashi Pharmaceutical focuses on creating innovative and niche products designed to solve specific, everyday problems for consumers, reflecting its brand slogan, 'You make a wish and we make it happen'.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and explicitly references '金融商品取引法第24条の4の8第1項' (Article 24-4-8, Paragraph 1 of the Financial Instruments and Exchange Act). It serves as an officer certification confirming the accuracy of the quarterly report, rather than being the quarterly report itself. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS). Q2 2023
2023-08-10 Japanese
四半期報告書－第106期第2四半期(2023/04/01－2023/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Kobayashi Pharmaceutical Co., Ltd., covering the period from January 1, 2023, to June 30, 2023. It includes detailed financial statements, management analysis, and auditor review information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2023
2023-08-10 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and explicitly references '金融商品取引法第24条の4の8第1項' (Article 24-4-8, Paragraph 1 of the Financial Instruments and Exchange Act). It serves as an officer certification regarding the accuracy of a quarterly report, rather than the quarterly report itself. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS). Q1 2023
2023-05-12 Japanese
四半期報告書－第106期第1四半期(2023/01/01－2023/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Kobayashi Pharmaceutical Co., Ltd. covering the period from January 1, 2023, to March 31, 2023. It contains detailed financial statements, including the consolidated balance sheet, income statement, and comprehensive income statement, as well as notes to the financial statements. This meets the criteria for an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. Q1 2023
2023-05-12 Japanese
内部統制報告書－第105期(2022/01/01－2022/12/31)
Governance Information Classification · 100% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act of Japan. It details the company's framework, scope, and evaluation results regarding internal controls over financial reporting. As this is a specific regulatory requirement for internal control assessment rather than a full annual report, a quarterly report, or a simple announcement, it falls under the 'Regulatory Filings' category as a specialized compliance document.
2023-03-30 Japanese
確認書
Audit Report / Information Classification · 95% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under Article 24-4-2 of the Financial Instruments and Exchange Act of Japan. This is a mandatory internal control certification document that accompanies the Annual Securities Report (Yukashoken Hokokusho). Since it is a regulatory filing confirming the accuracy of the annual report and does not constitute the full annual report itself, it falls under the general regulatory filing category. FY 2022
2023-03-30 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.